TNFRSF13B Polyclonal Antibody

$L1 mouse brain lysates L2 mouse heart lysates probed with Anti TNFRSF13B Polyclonal Antibody, Unconjugated (bs-2773R) at 1:200 in 4\u02daC. Followed by conjugation to secondary antibody (bs-0295G-HRP) at 1:3000 90min in RT. Predicted band 32kD. Observed band size: 32kD$

L1 mouse brain lysates L2 mouse heart lysates probed with Anti TNFRSF13B Polyclonal Antibody, Unconjugated (bs-2773R) at 1:200 in 4\u02daC. Followed by conjugation to secondary antibody (bs-0295G-HRP) at 1:3000 90min in RT. Predicted band 32kD. Observed band size: 32kD

$Lane 1: Mouse Spleen lysates; Lane 2: Mouse Lymph node lysates probed with TNFRSF13B Polyclonal Antibody, Unconjugated (bs-2773R) at 1:1000 dilution and 4\u02daC overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.$

Lane 1: Mouse Spleen lysates; Lane 2: Mouse Lymph node lysates probed with TNFRSF13B Polyclonal Antibody, Unconjugated (bs-2773R) at 1:1000 dilution and 4\u02daC overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.

$Lane 1: Mouse Spleen lysates; Lane 2: Mouse Lymph node lysates; Lane 3: Mouse Thymus lysates; Lane 4: Mouse Bone lysates probed with TNFRSF13B Polyclonal Antibody, Unconjugated (bs-2773R) at 1:1000 dilution and 4\u02daC overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.$

Lane 1: Mouse Spleen lysates; Lane 2: Mouse Lymph node lysates; Lane 3: Mouse Thymus lysates; Lane 4: Mouse Bone lysates probed with TNFRSF13B Polyclonal Antibody, Unconjugated (bs-2773R) at 1:1000 dilution and 4\u02daC overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.

$Lane 1: Mouse Spleen tissue lysates; Lane 2: Mouse Stomach tissue lysates; Lane 3: Mouse Cerebrum tissue lysates; Lane 4: Mouse Lung tissue lysates; Lane 5: Rat Stomach tissue lysates probed with TNFRSF13B Polyclonal Antibody, Unconjugated (bs-2773R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.$

Lane 1: Mouse Spleen tissue lysates; Lane 2: Mouse Stomach tissue lysates; Lane 3: Mouse Cerebrum tissue lysates; Lane 4: Mouse Lung tissue lysates; Lane 5: Rat Stomach tissue lysates probed with TNFRSF13B Polyclonal Antibody, Unconjugated (bs-2773R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.

Applications

WB
ELISA
IHC-P
IHC-F
IF(IHC-P)
IF(IHC-F)
IF(ICC)

Reactivity

Mouse
Rat

Overview
Catalog #	bs-2773R
Product Name	TNFRSF13B Polyclonal Antibody
Applications	WB ELISA IHC-P IHC-F IF(IHC-P) IF(IHC-F) IF(ICC)
Reactivity	Mouse, Rat
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from mouse TNFRSF13B
Immunogen Range	21-120/249
Clonality	Polyclonal
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	57916
Swiss Prot	Q9ET35
Subcellular location	Cell membrane
Synonyms	Taci; 1200009E08Rik; Tumor necrosis factor receptor superfamily member 13B; Transmembrane activator and CAML interactor; CD267; Tnfrsf13b
Background	Receptor for TNFSF13/APRIL and TNFSF13B/TALL1/BAFF/BLYS that binds both ligands with similar high affinity. Mediates calcineurin-dependent activation of NF-AT, as well as activation of NF-kappa-B and AP-1. Involved in the stimulation of B- and T-cell function and the regulation of humoral immunity (By similarity).
Application Dilution
WB	1:300-5000
ELISA	1:500-1000
IHC-P	1:200-400
IHC-F	1:100-500
IF(IHC-P)	1:50-200
IF(IHC-F)	1:50-200
IF(ICC)	1:50-200